The pathogenesis of sepsis is characterized by overwhelming inflammatory responses that lead to tissue damage and organ failure. Toll-like receptor (TLR) signaling is crucial for induction of hyperinflammatory responses and tissue injury during sepsis.
INTRODUCTION
blocked for 1 h at room temperature with 5% skim milk powder in TBS/T. Blots were then incubated overnight at 4°C with primary antibodies. After washing three times for 5 min each in TBS/T, the membranes were incubated with appropriate secondary antibodies for 1 h at room temperature, followed by detection using an ECL detection system (iNtRON Biotechnology Inc.), according to the manufacturer's instructions. Intensity of the immunoreactive bands was determined using TotalLab TL120 software (Nonlinear Dynamics Ltd., Newscastle, UK). Primary antibodies against mouse TLR2, TLR4, MyD88, NF-κB/p65, and IκB-α (SantaCruz Biotechnology, Santa Cruz, CA, USA), TRIF and HMGB1 (Abcam, Cambridge, MA, USA), p38, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), IFN regulatory factor (IRF)3, phosphor-p38, -ERK, and JNK, and phospho-IRF3 (Cell Signaling Technology, Beverly, MA, USA) were used and the signals were standardized to β-actin (Sigma Chemical Co., St. Louis, MO, USA) for whole lysate and lamin B1 (Abcam) for the nuclear fraction.
Statistical analysis
Survival data were analyzed by the Kaplan-Meier curve and log-rank test. All other data were analyzed by two-way analysis of variance, and the Bonferroni test was used for post hoc comparisons. Differences between the groups were considered statistically significant at p value < 0.05. Results are presented as mean ± S.E.M.
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RESULTS

Effect of genipin on CLP-induced mortality
In the vehicle-treated CLP group, the survival rate on the first day of observation was 60% and reached a stable 20% survival on the fifth day after CLP. Log-rank analysis of 10-day survival demonstrated that genipin at doses of 2.5 and 5 mg/kg significantly improved survival of septic mice, compared with sham animals (p=0.0119 and p=0.0435, respectively, Fig. 1A ). Repeated administration of genipin 2.5 mg/kg at a 24 h intervals resulted in a further increase of the survival rate at 10 days after CLP (Fig. 1B) .
Effect of genipin on organ injuries induced by CLP
Serum ALT activity in the sham group remained at 9.8 ± 0.8 16.1 ± 1.5 U/l throughout the experiments. While no significant change was observed in ALT activity until 3 h after CLP, serum ALT activity began to increase from 6 h after CLP, peaked at 202.8 ± 23.8 U/l at 24 h after CLP, and then declined to 88.3 ± 4.2 U/l at 48 h after CLP.
Increases in serum ALT activity that occurred at 12 and 24 h after CLP were attenuated by genipin. Serum AST activity in the sham group remained at the basal level until 48 h after surgery. Serum AST activity began to increase from 3 h after CLP, peaked at 375.6 ± 50.8
U/l at 24 h after CLP, and then declined to 196.0 ± 23.3 U/l at 48 h after CLP. Genipin attenuated elevations in serum AST activity that occurred at 12 and 24 h after CLP. The serum BUN level averaged 11.4 ± 0.7 mg/dl in the sham group. The serum BUN level began to increase from 6 h after CLP; this elevation persisted until 12 h (66.9 ± 10.6 mg/dl), and, thereafter, showed a gradual decrease until 48 h after CLP. Elevations in the serum BUN level that occurred at 12 and 24 h after CLP were attenuated by genipin. (11), but also possesses the ability for inhibition of lipid peroxidation and production of nitric oxide (12). Here, we demonstrated the protective effect of genipin against septic injury.
UNCORRECTED PROOF
In a survival study, we showed that a single dose of genipin administered immediately after CLP induced markedly improved survival. Twice administration of genipin at a 24 h interval further conferred protection against lethal sepsis. Since widening of the therapeutic window is a critical necessity, we tried delayed administration of genipin after onset of sepsis. Unfortunately, genipin only showed a tendency to increase survival when administered 6 or 24 h after CLP (data not shown). In vivo studies with acute endotoxemia demonstrated that genipin improved survival.
A largely unopposed early proinflammatory response is known to occur in severe sepsis, and leads to death (13). Indeed, the serum level of proinflammatory cytokines TNF-α, IL-1β, and IL-6 peaked at early time points during sepsis. Early proinflammatory cytokines, such as TNF-α and IL-1β, can also activate monocytes/macrophages for release of HMGB1, a late mediator of lethal sepsis (14). Circulating HMGB1 levels are elevated
in a delayed fashion in septic mice and in patients with sepsis, and are well correlated with the lethal outcome of human sepsis (15). A number of agents that blocked HMGB1 release, resulting in improved survival in experimental sepsis, have been identified (16, 17) . In our study, genipin induced marked suppression of the systemic release of early proinflammatory cytokines and subsequent HMGB1 accumulation in polymicrobial sepsis.
Excessive production of proinflammatory cytokines causes capillary leakage, tissue injury, and lethal organ failure in cases of severe sepsis. Multiple organ dysfunction syndrome is a serious clinical entity and a common cause of death in the critically ill patient. Overall mortality rates range from 30% to 100%, depending on the number of organ systems involved (18). In our study, LDH, a representative marker of tissue breakdown, particularly in the heart, began to increase from 1 h after CLP, indicating that heart muscle is damaged earlier than in other vital organs during sepsis. cyclohexane derivative, which selectively inhibits TLR4 signaling, was reported to inhibit increases in serum cytokine levels and to improve survival in an E.coli-induced sepsis model (24). In our study, TLR2 and 4 protein expression were significantly upregulated in both lung and liver at 6 and 24 h after CLP. Of particular interest, TLR2 and 4 protein expression showed a more dramatic increase in the lung than in the liver. Genipin attenuated increases in TLR2 and 4 protein expression in lung and liver, suggesting that the protective effect of genipin against septic injury might be mediated by suppression of TLR2 and 4 overexpression.
TLR2 signaling occurs exclusively through MyD88, whereas TLR4 can activate both
MyD88-dependent and MyD88-independent pathways. Weighardt et al. (25) showed that genetic deficiency of MyD88 partially protected mice from the lethal effects of polymicrobial sepsis and that the hyperinflammatory response to sepsis was strongly attenuated in the absence of MyD88. MyD88 is the central adaptor protein for signal transduction of most TLRs and interacts with TLRs, leading to activation of the MAPK cascade and NF-κB, causing expression of proinflammatory mediators (26). In the present study, the MyD88 protein expression in both lung and liver showed an increase at 6 and 24 h after CLP. Genipin attenuated the increase in MyD88 protein expression in both lung and liver.
Among MAPKs, activation of p38 and JNK has been shown to contribute to sepsisinduced end organ injury (27, 28). Removal of ERK by specific inhibitors resulted in reduced activation of NF-κB, suppressed transcription of NF-κB-dependent genes, and protected against LPS-induced endotoxemia (29). In our study, p38, ERK, and JNK were activated at 6 and 24 h after CLP in the lung. However, in the liver, p38 was activated only at 6 h after CLP, while ERK and JNK were activated at both 6 and 24 h after CLP. Maitra Significantly different ( * p < 0.05, ** p < 0.01) from saline. UNCORRECTED PROOF
